Mineralys Therapeutics | 4:持股变动声明-高管 Rodman David Malcom
04/16 04:29
Mineralys Therapeutics | EFFECT:其他
04/12 18:07
Mineralys Therapeutics | 424B5:募资说明书
04/12 04:42
Mineralys Therapeutics | ARS:年度报告
04/09 19:24
Mineralys Therapeutics | DEFA14A:其他
04/09 19:20
Mineralys Therapeutics | DEF 14A:股东委托书决议
04/09 19:19
Mineralys Therapeutics | 8-K:重大事件
04/04 20:05
Mineralys Therapeutics | S-3/A:特定交易注册声明(修正)
03/30 04:48
Mineralys Therapeutics | 8-K:Mineralys Therapeutics公布2023年第四季度和全年财务业绩并提供公司最新情况
03/21 19:46
Mineralys Therapeutics | S-3:特定交易注册声明
03/21 19:36
Mineralys Therapeutics | 10-K:年度报表
03/21 19:21
Mineralys Therapeutics | 4:持股变动声明-高管 Rodman David Malcom
03/14 05:40
Mineralys Therapeutics | 4:持股变动声明-高管 Rodman David Malcom
02/16 05:28
Mineralys Therapeutics | 4:持股变动声明-高管 Levy Adam Scott
02/16 05:28
Mineralys Therapeutics | 4:持股变动声明-高管 Congleton Jon
02/16 05:28
Mineralys Therapeutics | SC 13G:超过5%持股股东披露文件-TCG Crossover GP II, LLC(6.4%),TCG Crossover Fund II, L.P.(6.4%)等
02/16 05:23
Mineralys Therapeutics | 4:持股变动声明-董事 AKKARAJU SRINIVAS
02/15 10:08
Mineralys Therapeutics | 4:持股变动声明-股东 Samsara BioCapital GP, LLC
02/15 10:08
Mineralys Therapeutics | 4:持股变动声明-董事 RA CAPITAL MANAGEMENT, L.P.
02/15 08:53
Mineralys Therapeutics | SC 13G:超过5%持股股东披露文件-Adams Street Partners, LLC(5.60%),Adams Street Growth Equity Fund VII LP(2.17%)等
02/14 19:07
暂无数据
暂无数据